ÂÜÀòÂÒÂ×

In August 2022, D’Orazio was named the CEO of Phoenix LLC, which operates the industrial imaging arm of the business. D’Orazio brought with him more than two decades of experience in sales leadership roles for start-ups, emerging and established companies across health care, biotech and software industries. He most recently was the Chief Operating Officer for Tryp Therapeutics, a clinical-stage pharma company, where he was also a founding member. Prior to Tryp, he was CEO and President at ImmnoPrecise Antibodies, a scientific services and research organization. D’Orazio holds a bachelor’s degree in chemistry from Loyola University of Chicago and an MBA from Vanderbilt University with concentrations in marketing and finance.